| 4453 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
cherry angioma |
NC |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
=0.201 |
|
in vivo |
Homo sapiens |
Cherry angioma |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4454 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
cherry angioma |
NC |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
=0.201 |
|
in vivo |
Homo sapiens |
Cherry angioma |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4673 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type I |
NC |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type I |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4674 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type I |
NC |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type I |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4675 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type I |
NC |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type I |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 4677 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type II |
NC |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type II |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4678 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type II |
NC |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type II |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4679 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type II |
NC |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type II |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 4680 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type III |
NC |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type III |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4681 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type III |
NC |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type III |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4682 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type III |
NC |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type III |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 4683 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type IV |
NC |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type IV |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4684 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type IV |
NC |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type IV |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4685 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type IV |
NC |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type IV |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 4686 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type V |
NC |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type V |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4687 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type V |
NC |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type V |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4688 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
Fitzpatrick skin type V |
NC |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
=0.408 |
|
in vivo |
Homo sapiens |
Fitzpatrick skin type V |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 4799 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
lichenification |
UP |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Lichenification |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 4800 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
lichenification |
UP |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Lichenification |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 4801 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
lichenification |
UP |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Lichenification |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 5248 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
xerosis |
UP |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Xerosis |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 5249 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
xerosis |
UP |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Xerosis |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 5250 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
xerosis |
UP |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Xerosis |
Phenotype |
87 |
74 |
Clinical examination |
NM |
| 5984 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
malignant neoplasm |
UP |
Cohort |
Chronic nerve agent exposure |
Chronic Sulfur Mustard Exposure |
<0.0001 |
|
in vivo |
Homo sapiens |
Malignant tumors |
Phenotype |
154 |
175 |
Clinical examination |
NM |
| 6247 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
post-inflammatory hyperpigmentation |
UP |
Case-Control |
Chronic Sulfur Mustard Exposure |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Post-lesional hyperpigmentation |
Phenotype |
87 |
71 |
Clinical examination |
NM |
| 6248 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
post-inflammatory hyperpigmentation |
UP |
Case-Control |
non_healthy Control |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Post-lesional hyperpigmentation |
Phenotype |
87 |
78 |
Clinical examination |
NM |
| 6249 |
Chronic Sulfur Mustard Exposure |
Skin Biopsy |
post-inflammatory hyperpigmentation |
UP |
Case-Control |
Healthy Control |
Chronic Sulfur Mustard Exposure |
<0.001 |
|
in vivo |
Homo sapiens |
Post-lesional hyperpigmentation |
Phenotype |
87 |
74 |
Clinical examination |
NM |